Metis Global Partners LLC lessened its holdings in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 26.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,025 shares of the insurance provider’s stock after selling 4,330 shares during the quarter. Metis Global Partners LLC’s holdings in Allstate were worth $2,421,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Price T Rowe Associates Inc. MD grew its holdings in Allstate by 25.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock valued at $2,424,710,000 after buying an additional 2,374,684 shares in the last quarter. Boston Partners increased its holdings in shares of Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock worth $512,627,000 after purchasing an additional 2,134,893 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Allstate by 27.2% in the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock worth $482,073,000 after buying an additional 497,982 shares in the last quarter. Strs Ohio purchased a new position in Allstate during the first quarter worth about $84,408,000. Finally, AQR Capital Management LLC increased its holdings in shares of Allstate by 20.3% in the 1st quarter. AQR Capital Management LLC now owns 2,018,403 shares of the insurance provider’s stock worth $417,244,000 after buying an additional 340,150 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
ALL has been the topic of a number of recent research reports. UBS Group raised their price objective on Allstate from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, October 8th. BMO Capital Markets increased their price target on Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a report on Friday. Raymond James Financial reaffirmed a “strong-buy” rating and set a $260.00 price target (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. Wolfe Research raised shares of Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Allstate in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $236.53.
Allstate Stock Up 2.2%
Shares of NYSE:ALL opened at $202.29 on Monday. The Allstate Corporation has a 1 year low of $176.00 and a 1 year high of $215.70. The business has a 50 day simple moving average of $201.86 and a two-hundred day simple moving average of $201.23. The firm has a market capitalization of $52.94 billion, a PE ratio of 9.51, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.
Allstate (NYSE:ALL – Get Free Report) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 EPS for the quarter, topping analysts’ consensus estimates of $5.48 by $5.69. The business had revenue of $17.26 billion during the quarter, compared to the consensus estimate of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The firm’s revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the company posted $3.91 earnings per share. On average, equities analysts predict that The Allstate Corporation will post 18.74 EPS for the current year.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- How to Choose Top Rated Stocks
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
